A'Hern R - Search Results

1

Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma.

Lee CP, Patel PM, Selby PJ, Hancock BW, Mak I, Pyle L, James MG, Beirne DA, Steeds S, A'Hern R, Gore ME, Eisen T. Lee CP, et al. J Clin Oncol. 2006 Feb 20;24(6):898-903. doi: 10.1200/JCO.2005.03.7309. J Clin Oncol. 2006. PMID: 16484699 Clinical Trial.

2

Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose.

Harrison ML, Obermueller E, Maisey NR, Hoare S, Edmonds K, Li NF, Chao D, Hall K, Lee C, Timotheadou E, Charles K, Ahern R, King DM, Eisen T, Corringham R, DeWitte M, Balkwill F, Gore M. Harrison ML, et al. J Clin Oncol. 2007 Oct 10;25(29):4542-9. doi: 10.1200/JCO.2007.11.2136. J Clin Oncol. 2007. PMID: 17925549 Clinical Trial.

3

Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence.

Kolomainen DF, Larkin JM, Badran M, A'Hern RP, King DM, Fisher C, Bridges JE, Blake PR, Barton DP, Shepherd JH, Kaye SB, Gore ME. Kolomainen DF, et al. J Clin Oncol. 2002 Feb 15;20(4):982-6. doi: 10.1200/JCO.2002.20.4.982. J Clin Oncol. 2002. PMID: 11844820

4

Impact of doxorubicin on survival in advanced ovarian cancer.

A'Hern RP, Gore ME. A'Hern RP, et al. J Clin Oncol. 1995 Mar;13(3):726-32. doi: 10.1200/JCO.1995.13.3.726. J Clin Oncol. 1995. PMID: 7884432

5

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer.

Eisen T, Boshoff C, Mak I, Sapunar F, Vaughan MM, Pyle L, Johnston SR, Ahern R, Smith IE, Gore ME. Eisen T, et al. Br J Cancer. 2000 Feb;82(4):812-7. doi: 10.1054/bjoc.1999.1004. Br J Cancer. 2000. PMID: 10732751 Free PMC article. Clinical Trial.

6

The treatment of advanced renal cell cancer with high-dose oral thalidomide.

Stebbing J, Benson C, Eisen T, Pyle L, Smalley K, Bridle H, Mak I, Sapunar F, Ahern R, Gore ME. Stebbing J, et al. Br J Cancer. 2001 Sep 28;85(7):953-8. doi: 10.1054/bjoc.2001.2025. Br J Cancer. 2001. PMID: 11592764 Free PMC article. Clinical Trial.

7

Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma.

Waters JS, Moss C, Pyle L, James M, Hackett S, A'hern R, Gore M, Eisen T. Waters JS, et al. Br J Cancer. 2004 Nov 15;91(10):1763-8. doi: 10.1038/sj.bjc.6602209. Br J Cancer. 2004. PMID: 15505625 Free PMC article. Clinical Trial.

8

Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment.

Hess V, A'Hern R, Nasiri N, King DM, Blake PR, Barton DP, Shepherd JH, Ind T, Bridges J, Harrington K, Kaye SB, Gore ME. Hess V, et al. J Clin Oncol. 2004 Mar 15;22(6):1040-4. doi: 10.1200/JCO.2004.08.078. J Clin Oncol. 2004. PMID: 15020606

9

Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma.

Sandhu SS, Symes A, A'Hern R, Sohaib SA, Eisen T, Gore M, Christmas TJ. Sandhu SS, et al. BJU Int. 2005 Mar;95(4):522-5. doi: 10.1111/j.1464-410X.2005.05331.x. BJU Int. 2005. PMID: 15705072

10

Can patients with relapsed, previously untreated, stage I epithelial ovarian cancer be successfully treated with salvage therapy?

Kolomainen DF, A'Hern R, Coxon FY, Fisher C, King DM, Blake PR, Barton DP, Shepherd JH, Kaye SB, Gore ME. Kolomainen DF, et al. J Clin Oncol. 2003 Aug 15;21(16):3113-8. doi: 10.1200/JCO.2003.06.119. J Clin Oncol. 2003. PMID: 12915602

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters